Palisade Bio, Inc.
PALI
$1.67
-$0.17-9.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.75% | 31.76% | 36.77% | -12.55% | 3.03% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -- | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,381.82% | -80.34% | -34.00% | 9.36% | -97.50% |
| Change in Net Operating Assets | -412.57% | 613.39% | -203.57% | 3,268.18% | -30.63% |
| Cash from Operations | -13.41% | 48.07% | 26.64% | 13.29% | -17.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 10.71% | -- | 49.37% | -54.46% | 26.32% |
| Issuance of Common Stock | -- | -99.90% | -- | 26,005.88% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -554.41% | 100.00% | 44.55% | -140.00% | -353.33% |
| Cash from Financing | 1,968.33% | -99.89% | -112.75% | 3,205.97% | -111.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.27% | -2,454.55% | -124.13% | 161.84% | -203.67% |